Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide As First-Line Therapy for Extensive-Stage SCLC
Journal of Thoracic Oncology（2016）
Key words
Small cell lung cancer,Ipilimumab,Autoantibodies,Biomarker,CTLA-4 immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined